ArticleImmune network2017

Comparison of the Commercial QuantiFERON-CMV and Overlapping Peptide-based ELISPOT Assays for Predicting CMV Infection in Kidney Transplant Recipients.

Ji-Soo Kwon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.